10 parameters
-
Method:
MOR - MDMA - MAMP - COC - THC - AMP - BZO - BAR - PCP - MTD
-
Package:
10t
-
Product code:
DOA-10
-
CE:
CE
-
Storage temperature:
4 - 30 °C
-
Clinical significance:
Urine based screened tests for drugs of abuse of abuse range from simple immunoassay tests to complex analytical procedures. The speed of immunoassays has made them the most widely accepted method for screening urine for drugs of abuse. Our Drug screen card are based on the principle of highly specific immunochemical reactions of antibodies which are used for the analysis of specific compounds in biological fluids. The drug screen card is a rapid, visual, competitive panel immunoassay that can be used for the simultaneous, qualitative detection of multiple drug metabolites in human urine.
-
Intended use:
The Cypress Diagnostics Drug Screen card is a lateral flow, one-step panel immunoassay for the qualitative detection of multiple drug metabolites in human urine at the following cut-off concentrations: MOR: 300 ng/mL AMP: 1000 ng/mL THC: 50 ng/mL COC: 300 ng/mL MAMP: 1000 ng/mL BZO: 300 ng/mL PCP: 25 ng/mL BAR: 300 ng/mL MTD: 300 ng/mL MDMA: 500 ng/mL This product is used to obtain a visual, qualitative result and is intended for professional use. The assay should not be used without proper supervision. This assay provides only a preliminary analytical test result. A more specific alternative chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) has been established as the preferred confirmatory method by the National Institute on Drug Abuse (NIDA).
